S&D Co (260970) Q3 2025 earnings summary

Executive summary

• Specializes in functional food ingredients and health supplements, with diversification into natural materials for cosmetics and household goods.

• Maintains strong domestic sales, with all products sold via direct B2B channels; no overseas sales yet but preparing for expansion.

• Holds 31 patents and multiple certifications (GMP, ISO, HACCP, HALAL), supporting product competitiveness and compliance.

Financial highlights

• 2025 Q3 cumulative revenue: KRW 112.87 billion, down from KRW 116.14 billion in 2024.

• Operating income for 2025 Q3: KRW 17.47 billion, net income: KRW 14.26 billion.

• Basic EPS for 2025 Q3: KRW 4,928, compared to KRW 5,256 in 2024.

• Total assets as of 2025 Q3: KRW 109.51 billion; equity: KRW 79.99 billion.

• Cash and cash equivalents decreased to KRW 12.45 billion from KRW 21.89 billion at 2024 year-end.

Outlook and guidance

• Actively pursuing business diversification, with new business purposes added to the articles of incorporation for future growth.

• No immediate plans for new business launches, but groundwork laid for expansion beyond food manufacturing.